Further, we used antigen-specific B cell sorting to isolate a mAb termed HTN-Gn1, which neutralizes HTNV in vitro at a potency similar to that of a modestly neutralizing and protective nAb (27), and a non-neutralizing mAb termed nnHTN-Gn2. This evidence concerns the gene GYG1 and hypertensive disorder.